Low protein diet with essential amino acids ketoanalogues combination can affect serum FGF-23 and Klotho levels in chronic kidney disease 3b-4 stages patients: randomized pilot study
- Authors: Milovanova L.Y.1, Kozlovskaya(Lysenko) L.V1, Androsova T.V1, Lebedeva M.V1, Taranova M.V1, Milovanova S.Y.1, Kondratyeva T.B1, Zubacheva D.O1, Tchebotareva N.V1, Kozlov V.V1, Kuchieva A.M1, Li O.A1, Reshetnikov V.A1
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 91, No 6 (2019)
- Pages: 47-56
- Section: Articles
- URL: https://journals.rcsi.science/0040-3660/article/view/59000
- DOI: https://doi.org/10.26442/00403660.2019.06.000252
- ID: 59000
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
L. Yu Milovanova
Sechenov First Moscow State Medical University (Sechenov University)
Email: Ludm.milovanova@gmail.com
д.м.н., проф. каф. внутренних, профессиональных болезней и ревматологии; тел.: +7(916)164-14-00; ORCID: 0000-0002-5599-0350 Sechenov First Moscow State Medical University (Sechenov University)
L. V Kozlovskaya(Lysenko)
Sechenov First Moscow State Medical University (Sechenov University)д.м.н., проф. каф. внутренних, профессиональных болезней и ревматологии; ORCID: 0000-0002-1166-7308 Sechenov First Moscow State Medical University (Sechenov University)
T. V Androsova
Sechenov First Moscow State Medical University (Sechenov University)к.м.н., доц. каф. внутренних, профессиональных болезней и ревматологии; ORCID: 0000-0002-9951-126X Sechenov First Moscow State Medical University (Sechenov University)
M. V Lebedeva
Sechenov First Moscow State Medical University (Sechenov University)к.м.н., доц. каф. внутренних, профессиональных болезней и ревматологии; ORCID: 0000-0002-5923-1837 Sechenov First Moscow State Medical University (Sechenov University)
M. V Taranova
Sechenov First Moscow State Medical University (Sechenov University)к.м.н., доц. каф. внутренних, профессиональных болезней и ревматологии; ORCID: 0000-0002-7363-6195 Sechenov First Moscow State Medical University (Sechenov University)
S. Yu Milovanova
Sechenov First Moscow State Medical University (Sechenov University)д.м.н., в.н.с. НИО здоровьесберегающих технологий Научно-технологического парка биомедицины; ORCID: 0000-0002-2687-6161 Sechenov First Moscow State Medical University (Sechenov University)
T. B Kondratyeva
Sechenov First Moscow State Medical University (Sechenov University)к.м.н., доц. каф. госпитальной терапии №1 лечебного факультета; ORCID: 0000-0001-7938-1763 Sechenov First Moscow State Medical University (Sechenov University)
D. O Zubacheva
Sechenov First Moscow State Medical University (Sechenov University)ординатор 1-го года каф. внутренних, профессиональных болезней и ревматологии; ORCID 0000-0001-8020-7041 Sechenov First Moscow State Medical University (Sechenov University)
N. V Tchebotareva
Sechenov First Moscow State Medical University (Sechenov University)к.м.н., доц. каф. внутренних, профессиональных болезней и ревматологии; ORCID 0000-0003-2128-8560 Sechenov First Moscow State Medical University (Sechenov University)
V. V Kozlov
Sechenov First Moscow State Medical University (Sechenov University)доц. каф. общественного здоровья и организации здравоохранения; ORCID: 0000-0002-2389-3820 Sechenov First Moscow State Medical University (Sechenov University)
A. M Kuchieva
Sechenov First Moscow State Medical University (Sechenov University)врач отделения нефрологии и гемодиализа; ORCID: 0000-0002-8360-7734 Sechenov First Moscow State Medical University (Sechenov University)
O. A Li
Sechenov First Moscow State Medical University (Sechenov University)ассистент каф. внутренних, профессиональных болезней и ревматологии, врач отделения нефрологии и гемодиализа; ORCID: 0000-0003-1739-677Х Sechenov First Moscow State Medical University (Sechenov University)
V. A Reshetnikov
Sechenov First Moscow State Medical University (Sechenov University)д.м.н., проф. каф. общественного здоровья и организации здравоохранения; ORCID 0000-0002-2987-7995 Sechenov First Moscow State Medical University (Sechenov University)
References
- Levin A, Stevens P.E, Bilous R.W, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150. doi: 10.1038/kisup.2012.73
- KDIGO 2017 Сlinical practice guideline for the diagnosis, evolution, prevention, and treatment of Сhronic kidney disease - mineral and bone disorder (CKD-MBD). Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. Kidney Int Suppl (2011). 2017 Jul;7(1):1-59. doi: 10.1016/j.kisu.2017.04.001
- Piccoli G.B, Capizzi I, Vigotti F.N, et al. Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary - alternative medicines? BMC Nephrol. 2016;17:1-13. doi: 10.1186/s12882-016-0275-x
- Rysz J, Franczyk B, Ciałkowska-Rysz A. The Effect of Diet on the Survival of Patients with Chronic Kidney Disease. Nutrients. 2017;9(5):495. doi: 10.3390/nu9050495
- Snelson M, Clarke R.E, Coughlan M.T. Stirring the Pot: Can Dietary Modification Alleviate the Burden of CKD? Nutrients. 2017;9(3):265. doi: 10.3390/nu9030265
- Bellizzi V, Di Iorio B.R, De Nicola L, et al. Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney Int. 2007;71(3):245-51. doi: 10.1038/sj.ki.5001955
- Zha Y, Qian Q. Protein Nutrition and Malnutrition in CKD and ESRD. Nutrients. 2017;9(3):208. doi: 10.3390/nu9030208
- Gutiérrez O.M, Mannstadt M, Isakova T, et al. Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis. N Engl J Med. 2008;359:584-92. doi: 10.1056/NEJMoa0706130
- Hu M.C, Shi M, Zhang J, et al. Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease. J Am Soc Nephrol. 2011;22:124-36. doi: 1681/ASN.2009121311
- Seiler S, Rogacev K.S, Roth H.J, et al. Associations of FGF-23 and sklotho with cardiovascular outcomes among patients with CKD stages 2-4. Clin J Am Soc Nephrol. 2014;9:1049-58. doi: 10.2215/CJN.07870713
- Krieger N.S, Culbertson C.D, Kyker-Snowman K, Bushinsky D.A. Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone. Am J Physiol Renal Physiol. 2012;303(3):431-6. doi: 10.1152/ajprenal.00199.2012
- Dalton G.D, Xie J, Sung-Wan An. New Insights into the Mechanism of Action of Soluble Klotho. Front Endocrinol (Lausann). 2017;8:323. doi: 10.3389/fendo.2017.00323
- Bartali B, Semba R.D, Araujo A.B. Klotho, FGF21 and FGF23: novel pathways to musculoskeletal health? J Frailty Aging. 2013;2(4):179-83. doi: 10.14283/jfa.2013.26
- Yilmaz M.I, Sonmez A, Saglam M, et al. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int. 2010;78:679-85. doi: 10.1038/ki.2010.194
- Lu X, Hu M.C. Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease. Kidney Dis (Karger Publishers). 2016;17:1-9. doi: 10.1159/000452880
- Kuczera P, Adamczak M, Wiecek A. Fibroblast growth factor-23 - A potential uremic toxin. Toxins (Basel). 2016;8(12):369. doi: 10.3390/toxins8120369
- Isakova T, Wahl P, Vargas G.S, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79:1370-8. doi: 10.1038/ki.2011.47
- Hu M.C, Shiizaki K, Kuroo M. Fibroblast growth factor 23 and klotho: Physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol. 2013; 75:503-33. doi: 10.1146/annurev-physiol-030212-183727
- Neyra J.A, Hu M.C. αKlotho and Chronic Kidney Disease. Vitam Horm. 2016;101:257-310. doi: 10.1016/bs.vh.2016.02.007
- Kuroo M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45-51. doi: 10.1038/36285
- Kurosu H, Yamamoto M, Clark J.D, et al. Suppression of Aging in Mice by the Hormone Klotho. Science. 2005;309:1829-33. doi: 10.1126/science.1112766
- Go A.S, Chertow G.M, Fan D. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. N Engl J Med (Massachusetts Med Soc). 2004;351:1296-305. doi: 10.1056/NEJMoa041031
- Hu M.C, Kuroo M, Moe O.W. Secreted Klotho And Chronic Kidney Disease. Adv Exp Med Biol. 2012;728:126-57. doi: 10.1007/978-1-4614-0887-1_9
- Hu M-C, Shi M, Cho H.J, et al. The erythropoietin receptor is a downstream effector of Klotho - induced cytoprotection. Kidney Int. 2013;84:468-81. doi: 10.1038/ki.2013.149
- De Borst M.H, Vervloet M.G, Ter Wee P.M. Cross talk between the renin - angiotensin - aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol. 2011;22:1603-9. doi: 10.1681/ASN.2010121251
- Milovanova L, Fomin V.V, Lysenko (Kozlovskaya) L.V, et al. Disorders in the System of Mineral and Bone Metabolism Regulators - FGF-23, Klotho and Sclerostin - in Chronic Kidney Disease: Clinical Significance and Possibilities for Correction. Chapter in the book «Chronic Kidney Disease». INTECH, 2017. ISBN 978-953-51-5463-1
- Милованов Ю.С, Лысенко Л.В, Милованова Л.Ю, Шилов Е.М. Клинические рекомендации «Питание больных на додиализных стадиях ХБП». Разработчик: Научное общество нефрологов России, Ассоциация нефрологов России. Москва, 2014.
- Cheng H-M, Chuang S-Y, Sung S-H, et al. Derivation and validation of Diagnostic thresholds for Central Blood Pressure Measurements based on Long-Term Cardiovascular Risks. J Am Coll Cardiol. 2013. 62(19):1780-7. doi: 10.1016/j.jacc.2013.06.029
- Mancia G, De Backer G, Dominiczak A, et al. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159-219. doi: 10.1093/eurheartj/eht151
- Ермоленко В.М., Волгина Г.В., Добронравов В.А. и соавт. Национальные рекомендации по минеральным и костным заболеваниям при хронических заболеваниях почек. Русское Диализное Общество (май 2010). Нефрология и Диализ. 2011;13(1):33-51.
- Garneata L, Stancu A, Dragomir D. Ketoanalogue-Supplemented Vegetarian Very Low-Protein Diet and CKD Progression. J Am Soc Nephrol. 2016;27(7):2164-76. doi: 10.1681/ASN.2015040369
- Rhee C.M, Ahmadi S-F, Kovesdy C.P. Low - protein diet for conservative management of chronic kidney disease: a systematic review and meta - analysis of controlled trials. J Cachexia Sarcopenia Muscle. 2018;9(2):235-45. doi: 10.1002/jcsm.12264
- Милованова Л.Ю., Мухин Н.А., Козловская Л.В. и др. Снижение сывороточного уровня белка клото у пациентов с хронической болезнью почек: клиническое значение. Вестник Российской Академии медицинских наук. 2016;71:288-96.
- Neyra J.A, Hu M.C. Potential application of klotho in human chronic kidney disease. Bone. 2017;100:41-49. doi: 10.1016/j.bone.2017.01.017
- Xie J, Cha S-K, An S-W, Kuroo M. Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart. Nat Commun. 2012;3:1238. doi: 10.1038/ncomms2240
- NasrAllah M.M, El-Shehaby A.R, Osman N.A, Fayad T, Nassef A, Salem M.M, et al. The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers. Nephron Extra. 2013;3(1):106-12. doi: 10.1159/000356118
- Steitz S.A, Speer M.Y, Curinga G, et al. Smooth muscle cell phenotypic transition associated with calcification: Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001;89:1147-54.
- Zhou D, Tan R.J, Fu H. Wnt/[beta]-catenin signaling in kidney injury and repair: a double - edged sword. Lab Invest. 2016;96:156-67. doi: 10.1038/labinvest.2015.153
- Fang Y, Ginsberg C, Seifert M, et al. CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol. 2014;25:1760-73. doi: 10.1681/ASN.2013080818